SARS-CoV-2 messenger RNA vaccination in healthy individuals generates immune
protection against COVID-19. However, little is known about SARS-CoV-2 mRNA vaccine-induced …

B cells are not limited to producing protective antibodies; they also perform additional
functions relevant to both health and disease. However, the relative contribution of functionally …

Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks
of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin …

The therapeutic mode of action of dimethyl fumarate (DMF), approved for treating patients
with relapsing-remitting multiple sclerosis, is not fully understood. Recently, we and others …

The molecular mechanisms that link the sympathetic stress response and inflammation
remain obscure. Here we found that the transcription factor Nr4a1 regulated the production of …

A small proportion of multiple sclerosis (MS) patients develop new disease activity soon
after starting anti-CD20 therapy. This activity does not recur with further dosing, possibly …

Important antibody-independent pathogenic roles of B cells are emerging in autoimmune
diseases, including multiple sclerosis (MS). The contrasting results of different treatments …

Clinical trial results demonstrating that B-cell depletion substantially reduces new relapses
in patients with multiple sclerosis (MS) have established that B cells play a role in the …

Human mesenchymal stem cells (hMSCs) are being increasingly pursued as potential
therapies for immune-mediated conditions, including multiple sclerosis. Although they can …

Objective: To examine the mechanism underlying the preferential CD8 + vs CD4 + T-cell
lymphopenia induced by dimethyl fumarate (DMF) treatment of MS. Methods: Total lymphocyte …